|
|
|
This is the preliminary program for the 2006 Joint Statistical
Meetings in Seattle, Washington.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2006 Program page |
= Applied Session,
= Theme Session,
= Presenter, Sheraton Seattle Hotel & Towers = “S”
112
|
Mon, 8/7/06, 8:30 AM - 10:20 AM | CC-204 |
| Bayesian Methods in Biopharmaceuticals - Contributed - Papers | ||
|
Biopharmaceutical Section, Biometrics Section, Section on Bayesian Statistical Science, ENAR |
||
| Chair(s): Priya Kulkarni, Merck Research Laboratories | ||
| 8:35 AM |
Bayesian Adaptive Noninferiority Assessment with Safety Measure — Melissa Spann, Eli Lilly and Company; Stacy Lindborg, Eli Lilly and Company; John W. Seaman, Baylor University
|
|
| 8:50 AM |
Bayesian Sequential Analysis for Survival Data — Lili Zhao, The University of Iowa; George G. Woodworth, The University of Iowa
|
|
| 9:05 AM |
Bayesian Approach for Predicting the Margin of Safety in Nonclinical Safety Assessment Studies: a Case Study — Gheorghe Doros, Yale University; Viencent Reynolds, Eli Lilly and Company; Eyas Aby-Raddad, Eli Lilly and Company
|
|
| 9:20 AM |
Bayesian and Composite Designs for Drug Combination Studies — Yuehui Wu, GlaxoSmithKline; Vladimir Dragalin, GlaxoSmithKline; Vlareii Fedorov, GlaxoSmithKline
|
|
| 9:35 AM |
A Bayesian Simulation-Based Approach in Investigating Physiologically-Based Drug-Drug Interaction Prediction — Zhiping Wang, Indiana University Purdue University Indianapolis; Lang Li, Indiana University; Stephen Hall, Indiana University
|
|
| 9:50 AM |
Bayesian Adaptive Dose Selection — Melissa Spann, Eli Lilly and Company; David Manner, Eli Lilly and Company; John W. Seaman, Baylor University
|
|
| 10:05 AM |
Predicting Phase III Trial — Madhuja Mallick, Merck Research Laboratories; Bret Musser, Merck Research Laboratories
|
|
|
JSM 2006
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |